AN-2690(Tavaborole)

  Cat. No.:  DC7061  
Chemical Structure
174671-46-6
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
AN-2690(Tavaborole), an antifungal agent with activity against Trichophyton species, in a topical solution formulation, for the potential treatment of onychomycosis.
Cas No.: 174671-46-6
Synonyms: Tavaborole; AN2690; AN 2690
SMILES: OB1OCC2=CC(F)=CC=C21
Formula: C7H6BFO2
M.Wt: 151.93
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: AN-2690, a broad-spectrum drug, is a very promising candidate for treatment of ungual and periungual infections with improved nail penetration and low keratin binding. AN-2690 is an antifungal agent with activity against Trichophyton species. AN-2690 inhibits yeast cytoplasmic leucyl-tRNA synthetase by Formation of a stable tRNA(Leu)-AN2690 adduct in the editing site of the enzyme. AN-2690 is currently in clinical trials For onychomycosis topical treatment.For the detailed information of AN-2690(Tavaborole), the solubility of AN-2690(Tavaborole) in water, the solubility of AN-2690(Tavaborole) in DMSO, the solubility of AN-2690(Tavaborole) in PBS buffer, the animal experiment (test) of AN-2690(Tavaborole), the cell expriment (test) of AN-2690(Tavaborole), the in vivo, in vitro and clinical trial test of AN-2690(Tavaborole), the EC50, IC50,and Affinity of AN-2690(Tavaborole), Please contact DC Chemicals.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC47656 Antifungal agent 11 Antifungal agent 11 shows the promising antifungal activity.
DC47655 Antifungal agent 12 Antifungal agent 12 is a novel fluconazole-based compound with promising antifungal activities.
DC47654 Antifungal agent 16 Antifungal agent 16 displays considerable antibacterial activity and superior antifungal activity with reference to ciprofloxacin and fluconazole, respectively.
DC47653 Antifungal agent 17 Antifungal agent 17 exhibits excellent antifungal properties against B. cinerea with an EC50 value of 2.86 μg/mL.
DC47652 Antifungal agent 19 Antifungal agent 19 shows the potent antifungal activity (EC50 = 0.72 μM).
DC47651 Antifungal agent 13 Antifungal agent 13 exhibits remarkable antifungal activity against Sclerotinia sclerotiorum with an EC50 value of 1.25 mg/L.
DC47650 Debneyol Debneyol exhibits more potent fungicidal activity than validamycin.
DC47649 Fungicide4 Fungicide4 shows the high activity against the P. infestans strain.
DC47648 Nystatin A3 Nystatin A3, produced by Streptomyces noursei, a biologically active component of nystatin complex. Antibiotic activity
DC47647 Antifungal agent 14 Antifungal agent 14 exhibits broad-spectrum activity against the fungal strains with excellent minimum inhibitory concentration values.
X